Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
29 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/29/3157767/0/en/Revolution-Medicines-Announces-Key-Leadership-Additions-including-Alan-Sandler-M-D-as-Chief-Development-Officer.html
10 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/10/3148221/0/en/Revolution-Medicines-Shares-New-Clinical-Results-Supporting-Initiation-of-RASolute-303-a-Global-Phase-3-Registrational-Trial-of-Daraxonrasib-in-First-Line-Metastatic-Pancreatic-Duc.html
06 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/06/3128636/0/en/Revolution-Medicines-Reports-Second-Quarter-2025-Financial-Results-and-Update-on-Corporate-Progress.html
30 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/30/3124445/0/en/Revolution-Medicines-to-Report-Financial-Results-for-Second-Quarter-2025-After-Market-Close-on-August-6-2025.html
24 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/24/3121401/0/en/Revolution-Medicines-Announces-Publication-of-a-Peer-Reviewed-Research-Paper-in-Science-on-the-Discovery-and-Development-of-Zoldonrasib-a-RAS-ON-G12D-Selective-Inhibitor.html
23 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/23/3120187/0/en/Revolution-Medicines-Announces-FDA-Breakthrough-Therapy-Designation-for-Elironrasib.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE